Loading
MI
Maven Income and Growth VCT 4 PLC Stock: price and insider trades · United Kingdom
1 insider bought €3,319 of shares over the last 90 days, the latest filed 28 Aug 2026.
Maven Income and Growth VCT 4 PLC: what insiders have been doing
This page follows insider dealings at Maven Income and Growth VCT 4 PLC as filed with RNS (LSE), a company from the Finance & Banking sector. Over the twelve months to 18 October 2026, the company's managers filed 7 filings, from 5 insiders.
Every open-market trade in the period is a purchase: 7 purchases worth €257k, from 5 insiders, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €115k from William Robert Nixon, disclosed on 17 February 2026. Those buying include 5 senior executives.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The last purchase on record was published on 28 August 2026, which is 50 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (UK MAR).
With 7 filings in twelve months, the company is more active than the median of 6 filings across the 831 companies we follow on the same exchange. Since 2023, the database holds 21 purchases and no sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at First Guaranty Bancshares, Inc. and BCB Bancorp Inc. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Insider Decl.
21
Thresholds
n/a
Buy Volume
€692,003
21 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleFraser Gray8 buys
Brian Colquhoun2 buys
Diane Nixon2 buys
William Robert Nixon2 buys
Since the insiders bought
- -99.0%Entry £0.41 · Close at T+30 £0.00
- -2.9%Entry £0.52 · Close at T+90 £0.50
- -2.9%Entry £0.52 · Close at T+90 £0.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,211 of 24,148 companies
51.3
score / 100
Value39
Quality64
FCF yld-1.1%
Earn yld1.9%
EV/EBITDA·
ROE0.6%
Gross mgn·
Net mgn73%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended November 2025 · cache
£0.41
Analyst consensus
Income statement
Revenue£1.7M
Net income£1.2M73.2% margin
Valuation
P/Book90.4x
Beta0.11
Balance sheet & cash
Market cap£63.9M
Free Cash Flow-£679k
Profitability & ownership
ROE0.6%
ROA0.4%
% insiders1.6%
% institutions0.0%
Last declaration on 28 August 2026
Declarations21 total
5,640 shares@ £0.50450.0044% mcap7.9% of flowLondonRNS:9745681
Canonical exit: 26 Nov 2026 (T+90)
2,135 shares@ £0.52720.3% of flowLondonRNS:9571050
Canonical exit: 13 Aug 2026 (T+90)
184,877 shares@ £0.540939.1% of flowLondonRNS:a27a2d58-da6e-4cc0-92ba-dcd408d23b0b
Canonical exit: 18 May 2026 (T+90)
184,877 shares@ £0.540956.2% of flowLondonRNS:b9a23fdd-55eb-491d-b771-2c13196bfb5d
Canonical exit: 18 May 2026 (T+90)
3,236 shares@ £0.54090.5% of flowLondonRNS:1368663f-7a71-4a73-b63f-0f4423bb4508
Canonical exit: 16 Apr 2026 (T+90)
9,243 shares@ £0.54091.6% of flowLondonRNS:692532ab-21f0-49a8-94bb-18112bbd4817
Canonical exit: 15 Apr 2026 (T+90)
23,109 shares@ £0.540961.6% of flowLondonRNS:da3d7d1c-5891-4fa1-8cc6-6e7a11f2373b
Canonical exit: 15 Apr 2026 (T+90)
8,489 shares@ £0.53971.4% of flowLondonRNS:5798574
Canonical exit: 27 Nov 2025 (T+90)
4,954 shares@ £0.5710.9% of flowLondonRNS:5657640
Canonical exit: 14 Aug 2025 (T+90)
12,611 shares@ £0.594738.4% of flowLondonRNS:5592970
Canonical exit: 25 Jun 2025 (T+90)
8,407 shares@ £0.59471.6% of flowLondonRNS:5544551
Canonical exit: 20 May 2025 (T+90)
84,076 shares@ £0.594729.5% of flowLondonRNS:5544545
Canonical exit: 20 May 2025 (T+90)
168,152 shares@ £0.594741.1% of flowLondonRNS:5544543
Canonical exit: 20 May 2025 (T+90)
4,927 shares@ £0.60191.0% of flowLondonRNS:5395255
Canonical exit: 16 Jan 2025 (T+90)
4,197 shares@ £0.60090.8% of flowLondonRNS:5197480
Canonical exit: 22 Aug 2024 (T+90)
40,512 shares@ £0.617114.3% of flowLondonRNS:5132455
Canonical exit: 4 Jul 2024 (T+90)
8,103 shares@ £0.61711.6% of flowLondonRNS:5061163
Canonical exit: 8 May 2024 (T+90)
16,207 shares@ £0.617100.0% of flowLondonRNS:5036007
Canonical exit: 16 Apr 2024 (T+90)
81,037 shares@ £0.61719.8% of flowLondonRNS:5035999
Canonical exit: 16 Apr 2024 (T+90)
3,666 shares@ £0.63170.7% of flowLondonRNS:4936118
Canonical exit: 11 Jan 2024 (T+90)
148,961 shares@ £0.6713100.0% of flowLondonRNS:4790346
Canonical exit: 31 Aug 2023 (T+90)
21 of 21 declarations
About Maven Income and Growth VCT 4 PLC
Maven Income and Growth VCT 4 PLC is a UK-listed Venture Capital Trust quoted on the London Stock Exchange (FTSE 100/250/AIM), in the United Kingdom. It is not a conventional bank or insurer; rather, it is a listed private equity-style vehicle designed to provide investors with long-term capital appreciation and income by backing growth-oriented small businesses. Its investment mandate is to build a diversified portfolio of qualifying UK investments, with a core focus on smaller unquoted companies and a selective exposure to AIM-quoted businesses. The strategy is centered on identifying companies with scalable business models, supporting management teams through growth phases, and realising value through successful exits. ([mavencp.com](https://www.mavencp.com/hubfs/MIG%204%20Annual%20Report%20YE%2031%20Dec%202024%20%283%29_web.pdf))
The company was launched on 26 August 2004. Over time, it evolved through a series of corporate combinations and legacy name changes: it was formerly Aberdeen Growth Opportunities VCT 2 PLC and later incorporated Maven Income and Growth VCT 6 PLC, Maven Income and Growth VCT 2 PLC, Ortus VCT PLC, and Gateway VCT PLC. That history underlines its status as a mature, consolidated VCT franchise rather than a start-up investment vehicle. Its registered office is in Glasgow, Scotland, at Kintyre House, 205 West George Street, Glasgow, G2 2LW. ([mavencp.com](https://www.mavencp.com/investment-opportunities/venture-capital-trusts/maven-income-and-growth-vct-4))
Read moreShow less
Operationally, Maven VCT 4 invests mainly in smaller UK unquoted companies and selected AIM companies with growth potential. The portfolio is diversified across a wide range of sectors, which is important given the inherently higher risk and lower liquidity associated with small-cap private market assets. The 2024 annual report explains that the board oversees a structured selection, monitoring and realisation process, while the manager is FCA-authorised and responsible for sourcing and managing investments. In competitive terms, the trust benefits from Maven’s regional UK office network and its long-standing expertise in SME investing, giving it access to a broad pipeline of regional opportunities and an established record in supporting entrepreneurial businesses. Maven itself was formed in 2009 after a management buyout of Aberdeen Asset Management’s private equity business and has since grown into one of the UK’s most active SME investors. ([mavencp.com](https://www.mavencp.com/hubfs/MIG%204%20Annual%20Report%20YE%2031%20Dec%202024%20%283%29_web.pdf))
Recent developments reinforce the company’s active investment profile. In January 2025, the broader set of Maven Income and Growth VCTs activated their over-allotment facility, expanding the fundraising capacity to £40 million in response to strong investor demand. In December 2025, Maven VCTs announced an initial £1.5 million investment in FITR, a London-based HealthTech platform serving fitness coaches and professionals. The trust also continues to release regular RNS disclosures, including PDMR and director shareholding notifications, reflecting the governance discipline expected of a listed UK vehicle. ([mavencp.com](https://www.mavencp.com/latest-news/maven-vcts-announce-activation-of-20m-vct-over-allotment-facilities))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
